resTORbio is a biopharmaceutical company developing therapeutics for treating age-related diseases that is headquartered in Boston, Massachusetts and was founded in 2016 by Chen Schor and Joan Mannick.
Funding
Series A
On January 1, 2017 resTORbio completed their series A funding round with $25 million in funding from PureTech Health.
Series B
On November 30, 2017 resTORbio completed their series B funding rounds with $40 million in funding from OrbiMed (lead investor), Rock Springs Capital, Recharge Capital, Quan Capital, Nest.Bio Ventures, and Fidelity Management and Research Company.
Timeline
Funding rounds
People
Chen Schor
Co-Founder, President and CEO
Joan Mannick
Co-Founder, Chief Medical Officer
Sarb Shergill
Vice President of Clinical Operations
Further reading
resTORbio launches Phase Ib/IIa trial of RTB101 to treat Parkinson's
Drugdevelopment-technology
Web
Documentaries, videos and podcasts
Companies
References
Company attributes
Categories
Related Topics
Contributors
- 1
Dawson Sewell
Seeking to explain science and technology through simple writing. - 2
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry. - 3
Rebecca Hammond
MA English I HDip Psychology - Following AI, behavioural and educational psychology - 4
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the universe. - 5
Aime Anne Nisay
QA Engineer of web and mobile applications - 6
Melanie Manipula
Researcher, writer and a former librarian - 7
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME